DJIA 16,488.94 137.56 0.84%
NASDAQ 4,781.54 31.56 0.66%
S&P 500 1,965.51 16.65 0.85%
market minute promo


13.15 -0.32 (-2.38%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

OMER $13.15 -2.38%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.45
Previous Close $13.47
Daily Range $13.03 - $13.74
52-Week Range $11.18 - $30.23
Market Cap $498.2M
P/E Ratio -6.41
Dividend (Yield) $0.00 (0.0%)
Volume 327,844
Average Daily Volume 2,331,951
Current FY EPS -$1.69




Drug Makers

Omeros (OMER) Description

Omeros Corporation is a clinical-stage Biopharmaceutical Company engaged in discovering developing and commercializing products focused on inflammation and disorders of the central nervous system. Website:

News & Commentary

Why Omeros Corporation's Stock Rocketed Higher Today

Omeros' shares rose by 85% on a clinical update for OMS721. Here's what investors need to know right now.

The Biotech Compound Drug Insight

'Mad Money' Lightning Round: Forget Omeros, Buy Celgene

Apple Hospitality Should Be Higher - Cramer's Lightning Round (9/1/15)

Omeros Slumps: OMER Falls 9.1% in Session

Omeros (OMER): Today's Weak On High Volume Stock

Watch For A Potential 50% Drop In Omeros

Where Is Omeros Corporation Now?

Omeros: Thoughts On Latest Developments

Financial Considerations Of Omeros Corporation

Omeros: This Small-Cap Biotech Stock Makes The Grade

See More OMER News...

OMER's Top Competitors

OMER $13.15 (-2.38%)
Current stock: OMER
AMGN $151.34 (-0.62%)
Current stock: AMGN
GILD $103.30 (-0.93%)
Current stock: GILD
BIIB $305.67 (0.48%)
Current stock: BIIB